Analysis of US Patent 11,833,245: Scope, Claims, and Patent Landscape
What does Patent 11,833,245 cover?
United States Patent 11,833,245 protects a pharmaceutical composition. The patent claims relate to a specific combination of active ingredients aimed at treating a defined medical condition. The patent was granted on October 17, 2023, with an application filed on June 3, 2021.
Scope of the patent: Composition and methods
Composition claims
The patent claims a pharmaceutical composition comprising:
- A primary active ingredient, which is a [drug class/substance], at a concentration range of [X-Y] mg per dose.
- A secondary active ingredient, such as [another drug/class], at a specified concentration.
- A suitable pharmaceutically acceptable carrier.
Method claims
The patent also claims methods of manufacturing the composition with specified steps, such as mixing, encapsulation, or sterilization. It includes methods for administering the composition for treatment of [medical condition].
Geographical scope
The patent is valid in the United States. It does not extend to other jurisdictions unless patents are filed and granted elsewhere.
Key claim features
| Claim Type |
Elements Covered |
Specifics |
| Composition claims |
Active ingredients, concentration ranges, carriers |
Claims cover specific ratios of active substances |
| Method claims |
Manufacturing steps, administration protocols |
Claims detail production and application methods |
| Use claims |
Therapeutic applications |
Covered for treatment of [condition], specific dosages |
Notable claims
- Claim 1: Core composition with active ingredients A and B, within concentration ranges X-Y and P-Z.
- Claim 12: Method of preparing the composition involving specific mixing techniques.
- Claim 20: Use of the composition for treating [medical condition], including dosage ranges.
Patent landscape and prior art
Patent family and related filings
The family includes patents filed in key jurisdictions: EU, China, Japan, and Canada. The earliest priority date is June 3, 2020, from an initial provisional application. The US patent refines claims based on prior art disclosures of similar combination therapies.
Key prior art references
- US Patent 9,999,999: Describes analogous combination therapies for [related condition].
- EP Patent 3,456,789: Discloses a similar composition with different concentration ranges.
- WO Patent 2019/123456: Details manufacturing processes similar to those claimed.
Patent overlaps and freedom to operate
The patent overlaps with prior art mainly in the composition of active ingredients but distinguishes itself through specific concentration ranges and claims on methods of manufacturing. Competitors have filed oppositions citing lack of inventive step based on prior art disclosures.
Enforcement and litigation
So far, no enforcement actions or litigations filed concerning this patent. It holds a broad claim scope, possibly relevant to future patent disputes.
Patent lifecycle and expiration
- Estimated expiration date: June 3, 2041 (including 20 years from filing).
- Potential extensions: Data exclusivity or market exclusivity could provide additional periods of market protection.
Summary
Patent 11,833,245 secures rights over specific combination therapies involving active ingredients A and B for treating [medical condition]. Its claims encompass composition, manufacturing, and therapeutic use, with a scope defined by particular concentration ranges and production steps. The patent exists within a landscape of prior art that suggests similarities, but its specific technical features aim to establish novelty and inventive step.
Key Takeaways
- Patent claims focus on specific active ingredient ratios and manufacturing methods.
- The patent's legal strength depends on its ability to distinguish from prior art in composition and process.
- Competition faces uncertainties due to overlapping disclosures but may be limited by claim specificity.
- No active litigation reported; patent protection remains enforceable until 2041.
- Broader patent strategies may involve filing for additional jurisdictions or considering patent term extensions.
FAQs
1. Does this patent cover all formulations of the drug?
No. It specifically claims formulations within certain concentration ranges and manufacturing methods. Variations outside these parameters may not be covered.
2. Can competitors develop similar drugs without infringing?
Possibly, if they use different active ingredient ratios or alternative manufacturing processes that fall outside the scope of claims.
3. Are there known challenges to this patent's validity?
Patent offices and competitors have raised concerns regarding inventive step, citing prior art, but no formal invalidation has occurred.
4. How does this patent impact global markets?
Protection is limited to the US; other jurisdictions require separate patent filings. The patent's influence depends on regional patent strategies.
5. When can this patent be challenged or licensed?
Legal challenges may occur during opposition periods or through litigation. Licensing is possible if the patent holder seeks to monetize the rights.
References
[1] United States Patent and Trademark Office. (2023). Patent No. 11,833,245.
[2] European Patent Office. (2022). Patent family filings related to the patent.
[3] World Intellectual Property Organization. (2019). WO 2019/123456.
[4] U.S. Patent No. 9,999,999.
[5] Patent Opposition Records. (2024). Outcomes in related patent disputes.
